ACRO BIOMEDICAL CO., LTD.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $685.9K | $18.1K |
| FY2021 | — | $643.7K | $95.2K |
| FY2022 | — | $486.4K | $5.9K |
| FY2023 | — | $-257.0K | $376 |
| FY2024 | — | $-295.0K | $476 |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $685.9K | $18.1K |
| FY2021 | — | $643.7K | $95.2K |
| FY2022 | — | $486.4K | $5.9K |
| FY2023 | — | $-257.0K | $376 |
| FY2024 | — | $-295.0K | $476 |